Antimicrobial-Resistant Pathogens Program Research
NYU Langone’s Antimicrobial-Resistant Pathogens Program is an applied research capability platform focused on antimicrobial-resistant pathogens. The program supports basic and clinical antimicrobial-resistant pathogen research through the following approaches:
- structures that seamlessly bridge clinical, molecular, and translational research
- an advanced microbial biorepository system that integrates a curated clinical database
- microbial comparative genomics facilitating state-of-the-art surveillance and target discovery
Our program brings together NYU Langone’s strengths in medicine, host–pathogen interaction, molecular epidemiology, immune response to infection, and -omics (genomics, proteomics, and metabolomics), to identify clinically relevant targets for the generation of biologics and vaccines. State-of-the-art microbial genomics is a critical component of our toolbox. Efficient deployment of this know-how is ensured through the program’s Microbial Genomics Core Lab.
We apply this coordinated, multipronged approach to a classic model of infectious disease causation that posits infectious disease results from a combination of pathogen, host, and environmental factors—the epidemiological triad.
Through multidisciplinary programs like ours, we are confident that we can identify novel approaches for managing antimicrobial-resistant pathogens.
Our Research Partners
We collaborate with many research programs, centers, scientific cores, and institutes, including the following:
- Vaccine Center
- Translational Immunology Center
- Center for Human Genetic and Genomics
- Ion Channels and Transporters in Immunity Research Program
- Perlmutter Cancer Center
- Cardiovascular Research Center
- Microbial Genomics Core Lab
- Genome Technology Center
Our Clinical Partners
We partner with a range of clinical departments, divisions, and laboratories, including the following:
